Poly (lactic-co-glycolic acid)(PLGA) particles carrying antigen and adjuvant is a promising
vaccine system which has been shown to stimulate systemic antigen-specific immune …

Purpose Allergen-specific immunotherapy (SIT) requires dozens of subcutaneous injections
over 3 to 5 years in order to control IgE-mediated hypersensitivity, which is a T-helper 2 …

Editorial Salem that promote Th1-biased allergen specific immune responses to reduce lung
damage linked with exposure to allergen [9]. Unmethylated cytosine-phosphateguanine …

Background Biodegradable microparticles, in particular poly (lactide‐co‐glycolide)(PLGA),
have been shown as potential delivery vehicles for intranasal (in) vaccines in animal …

BACKGROUND: Biodegradable poly (lactide-co-glycolide)(PLGA) microspheres are a
promising carrier for vaccine delivery capable of maturing antigen-presenting cells to …

Poly-(lactide-co-glycolide) microspheres with entrapped antigen have shown considerable
promise as controlled release vaccines. To enhance the immunomodulatory effect of LW …

Poly (lactic-co-glycolic acid)(PLGA) particles have been extensively studied as
biodegradable delivery system to improve the potency and safety of protein-based vaccines …

The goal of this study was to investigate whether poly (lactic-co-glycolic) acid (PLGA)
nanoparticles could enhance sublingual immunotherapy (SLIT) efficacy. BALB/c mice …

Encouraged by recent findings showing the usefulness of nonreplicating antigen delivery
systems in the induction of mucosal immune responses, we investigated microspheres as a …

Previous studies demonstrated in vitro phagocytosis of poly (lactide-co-glycolide)(PLGA)
microspheres (MS) by macrophages and dendritic cells and the biodistribution of fluorescent …